These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22404639)

  • 1. Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Beloncle F; Buffet M; Coindre JP; Munoz-Bongrand N; Malot S; Pène F; Mira JP; Galicier L; Guidet B; Baudel JL; Subra JF; Tanguy-Schmidt A; Pourrat J; Azoulay E; Veyradier A; Coppo P;
    Transfusion; 2012 Nov; 52(11):2436-44. PubMed ID: 22404639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
    Kappers-Klunne MC; Wijermans P; Fijnheer R; Croockewit AJ; van der Holt B; de Wolf JT; Löwenberg B; Brand A
    Br J Haematol; 2005 Sep; 130(5):768-76. PubMed ID: 16115135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.
    Aqui NA; Stein SH; Konkle BA; Abrams CS; Strobl FJ
    J Clin Apher; 2003; 18(2):51-4. PubMed ID: 12874815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: a retrospective cohort study.
    Outschoorn UM; Ferber A
    Am J Hematol; 2006 Dec; 81(12):895-900. PubMed ID: 16888787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
    Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
    Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].
    Cui J; Zhu TN; Zou N; Chen M; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):116-20. PubMed ID: 23469801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of thrombotic thrombocytopenic purpura.
    Coppo P;
    Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P; Froissart A;
    Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
    Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
    Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and relapse risks of thrombotic thrombocytopaenic purpura: an Egyptian experience.
    El-Husseiny NM; Goubran H; Fahmy HM; Tawfik NM; Moustafa H; Amin SN; El-Ekiaby M
    Postgrad Med J; 2012 Aug; 88(1042):433-6. PubMed ID: 22434913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms.
    Coppo P;
    Transfus Apher Sci; 2017 Feb; 56(1):52-56. PubMed ID: 28110841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange plus corticosteroid for the treatment of the thrombotic thrombocytopenic purpura: a single institutional experience in the southern Marmara region of Turkey.
    Ozkalemkas F; Ali R; Ozkocaman V; Ozcelik T; Ozkan A; Tunali A
    Transfus Apher Sci; 2007 Feb; 36(1):109-15. PubMed ID: 17291831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution.
    Onundarson PT; Rowe JM; Heal JM; Francis CW
    Arch Intern Med; 1992 Apr; 152(4):791-6. PubMed ID: 1558437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange.
    Höffkes HG; Weber F; Uppenkamp M; Meusers P; Teschendorf C; Philipp T; Brittinger G
    Semin Thromb Hemost; 1995; 21(2):161-5. PubMed ID: 7660138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
    Letchumanan P; Ng HJ; Lee LH; Thumboo J
    Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.